Bank of New York Mellon’s Greenwich LifeSciences GLSI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $132K | Buy |
14,596
+3,393
| +30% | +$30.8K | ﹤0.01% | 4021 |
|
|
2025
Q1 | $107K | Hold |
11,203
| – | – | ﹤0.01% | 3974 |
|
|
2024
Q4 | $126K | Hold |
11,203
| – | – | ﹤0.01% | 3988 |
|
|
2024
Q3 | $161K | Sell |
11,203
-4,092
| -27% | -$58.8K | ﹤0.01% | 3942 |
|
|
2024
Q2 | $264K | Buy |
+15,295
| New | +$264K | ﹤0.01% | 3858 |
|
|
2022
Q2 | – | Sell |
-10,114
| Closed | -$198K | – | 4640 |
|
|
2022
Q1 | $198K | Hold |
10,114
| – | – | ﹤0.01% | 4242 |
|
|
2021
Q4 | $246K | Buy |
10,114
+181
| +2% | +$4.4K | ﹤0.01% | 4178 |
|
|
2021
Q3 | $388K | Buy |
9,933
+3,269
| +49% | +$128K | ﹤0.01% | 3940 |
|
|
2021
Q2 | $300K | Buy |
+6,664
| New | +$300K | ﹤0.01% | 3967 |
|